KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Cash from Financing Activities (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Cash from Financing Activities for 11 consecutive years, with $22.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 113.48% year-over-year to $22.7 million, compared with a TTM value of -$860.4 million through Dec 2025, down 458.66%, and an annual FY2025 reading of -$860.4 million, down 458.66% over the prior year.
  • Cash from Financing Activities was $22.7 million for Q4 2025 at Medpace Holdings, up from $3.4 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $22.7 million in Q4 2025 and bottomed at -$540.6 million in Q2 2025.
  • Average Cash from Financing Activities over 5 years is -$100.9 million, with a median of -$50.0 million recorded in 2021.
  • The sharpest move saw Cash from Financing Activities surged 122.5% in 2021, then plummeted 81265.77% in 2025.
  • Year by year, Cash from Financing Activities stood at $2.4 million in 2021, then crashed by 5493.71% to -$131.1 million in 2022, then surged by 101.16% to $1.5 million in 2023, then crashed by 11170.85% to -$168.6 million in 2024, then soared by 113.48% to $22.7 million in 2025.
  • Business Quant data shows Cash from Financing Activities for MEDP at $22.7 million in Q4 2025, $3.4 million in Q3 2025, and -$540.6 million in Q2 2025.